Regulatory UK regulators greenlight Lilly’s Foundayo, intensifying Novo competition Pharmaceutical TechnologyThe MHRA is the first European regulator to give Foundayo a regulatory blessing, with the drug still under review by the EU.Metabolic & GLP-1Read full story pharminent August 11, 2026 (Last updated: August 14, 2026) Pharmaceutical Technology The MHRA is the first European regulator to give Foundayo a regulatory blessing, with the drug still under review by the EU. Metabolic & GLP-1 Read full story Post navigation Previous: BMS banks on Texas for $2.3bn multi-modal manufacturing facilityNext: Trump signs order that nearly halves childhood immunisation coverage Related Stories Regulatory Replimune rebounds to win FDA approval of melanoma drug pharminent August 6, 2026 Regulatory Takeda’s first-in-class narcolepsy drug claims FDA approval pharminent August 6, 2026 Regulatory Outlook Therapeutics Secures FDA Approval for LYTENAVA pharminent July 31, 2026
